Loading...
XJPX
7733
Market cap11bUSD
Jul 09, Last price  
1,741.00JPY
1D
-1.64%
1Q
11.00%
Jan 2017
72.38%
Name

Olympus Corp

Chart & Performance

D1W1MN
XJPX:7733 chart
P/E
28.12
P/S
1.90
EPS
61.91
Div Yield, %
1.15%
Shrs. gr., 5y
-2.84%
Rev. gr., 5y
6.71%
Revenues
1.01t
+1.34%
1,061,786,000,0001,128,875,000,000980,803,000,000883,086,000,000847,105,000,000848,548,000,000743,851,000,000713,286,000,000764,671,000,000804,578,000,000740,557,000,000786,497,000,000793,862,000,000755,231,000,000730,544,000,000750,123,000,000881,923,000,000925,752,000,000997,332,000,0001,010,676,000,000
Net income
68.17b
-42.16%
47,799,000,00057,969,000,000-114,810,000,00047,763,000,0003,866,000,000-48,985,000,0008,020,000,00013,627,000,000-8,737,000,00062,594,000,00042,783,000,00057,064,000,0008,147,000,00080,288,000,00057,712,000,000115,742,000,000143,432,000,000242,566,000,000117,855,000,00068,172,000,000
CFO
100.59b
-47.19%
108,400,000,00089,006,000,00041,628,000,00076,245,000,00030,469,000,00030,889,000,00025,233,000,00072,388,000,00066,811,000,00048,621,000,000102,052,000,00095,146,000,00066,943,000,000133,544,000,000124,122,000,000169,729,000,00098,490,000,00042,365,000,000190,463,000,000100,585,000,000
Dividend
Sep 29, 202630 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Tokyo, Japan, in 1919, Olympus Corporation is a global leader in the manufacturing and distribution of advanced precision machinery and scientific instruments. The company structures its diverse operations into four main segments. Its Endoscopic Solutions division provides sophisticated endoscopic tools for gastrointestinal and surgical procedures, along with complete endoscopy systems and crucial repair services. The Therapeutic Solutions segment delivers specialized medical devices for urology, gynecology, and otolaryngology (ear, nose, and throat), alongside endo-therapy and energy-based devices, and single-use surgical instruments. Under its Scientific Solutions umbrella, Olympus supplies an array of biological and industrial microscopes, industrial inspection equipment including endoscopes and videoscopes, non-destructive testing apparatus, and X-ray fluorescence (XRF) analyzers. The "Others" category encompasses biomedical materials and orthopedic equipment. Furthermore, Olympus's extensive offerings include additional medical technologies such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, supported by system integration and comprehensive maintenance and service programs. The company, which was originally known as Olympus Optical Co., Ltd., officially rebranded as Olympus Corporation in October 2003.
IPO date
May 16, 1949
Employees
32,844
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT